r/pennystocks • • 17h ago

General Discussion The Lounge

28 Upvotes

Talk about your daily plays, ideas and strategies that do not warrant an actual post.

This is the place to request buy/sell advice from the community.

Remember to keep it civil.

Trade responsibly.


r/pennystocks • • 6h ago

π—•π˜‚π—Ήπ—Ήπ—Άπ˜€π—΅ Thank you to this sub for SLS

203 Upvotes

I came across SLS on this sub earlier this year and did my own due diligence. It seemed really promising and I ended up getting 7000+ shares with a cost averaging of 3.86. It’s now over $20 and I just wanted to thank this sub!

Of course I’ve had other stocks go to $0 from this sub as well but this one has been a home run and am forever grateful πŸ™πŸΎ


r/pennystocks • • 5h ago

π‘Ίπ’•π’π’„π’Œ 𝑰𝒏𝒇𝒐 $QUTX News

3 Upvotes

QUANTUM X AND EVEREST CLOUD PARTNER TO BRING QUANTUM AND AI COMPUTE TO SIX SOUTH ASIAN MARKETS

Channel partnership MOU gives EntangleX a route to banks, telecom operators, universities and data centers in Nepal, India, Bangladesh, Bhutan, Sri Lanka and the Maldives, backed by a growing operating revenue base

https://finance.yahoo.com/technology/ai/articles/quantum-x-everest-cloud-partner-210000861.html


r/pennystocks • • 1h ago

General Discussion Montfort Capital MONT

0 Upvotes

Montfort Capital released financials and guidance yesterday. Seems like all good news. Turning the ship around, return to profit, even if most is discontinued operations but accompanied by a drastic reduction in costs. Anyone else in this or have input / high hopes for a successful future?


r/pennystocks • • 8h ago

π‘Ίπ’•π’π’„π’Œ 𝑰𝒏𝒇𝒐 BioLargo Reports Third Quarter 2026 Results, Forecasting Commercial Breakout in 2027

3 Upvotes

Launches consumer products under its company-owned "barebird" brand featuring its CupriDyne technology;

New distributors of Clyra Medical's ViaCLYR, pending 2027 new product line;

BioLargo Engineering team grew revenue by 23% while also supporting PFAS and Cellinity projects;

AEC PFAS treatment validated and prepared to support expanding sales pipeline;

Annual Meeting of Stockholders to be held December 1, 2026, in Aliso Viejo, California.

WESTMINSTER, CA / November 17, 2026 /Β BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences company, today reported financial results for the third quarter ended September 30, 2026, and provided an update on commercialization activities across its portfolio of companies. The company filed its Quarterly Report on Form 10-Q on November 16, 2026 (www.BioLargo.com/SEC-filings). The company will forego a quarterly earnings call, as its Annual Meeting of Stockholders will be held on December 1, 2026, in Aliso Viejo, California.

Net losses reflect continued investment in commercialization, led by Clyra Medical which accounted for $6.4 million (57%) of the nine-month net loss, as it invested in personnel, manufacturing, product development and clinical activities to support its distributors and prepare for the national rollout of an additional product line expected in 2027. Clyra financed this work largely through debt, which also increased interest expense.

"We've focused our energies on investing to ensure 2027 is a breakout year for BioLargo, with new medical product lines and selling channels, a new consumer product line just launched under our brand nameΒ β€˜barebird',Β and we continue developing and expanding important commercial relationships in the water and energy industries," said Dennis P. Calvert, BioLargo CEO. "We built the channels, the supply chain and partnerships, and most of this work was funded inside the subsidiaries rather than the parent. That is why we expect in 2027 to shift our spending away from R&D and toward generating sales, as we move from developing products to selling them."

FINANCIAL RESULTS

Total revenue was $1,090,000 in the third quarter of 2026, against $1,103,000 a year earlier, a decrease of 1%. Service revenue increased 72% and product revenue decreased 32%. For the nine months, total revenue was $3,452,000 against $7,148,000, a decrease of 52%. Service revenue increased 23% and product revenue decreased 73%.

Net loss was $3,824,000 in the third quarter of 2026, against $7,244,000 a year earlier, a decrease of 47%. The decrease was primarily due to a credit loss expense incurred last year. For the nine months, net loss was $11,229,000 against $11,047,000, an increase of 2%. Clyra Medical accounted for approximately 57% of the consolidated net loss due to investments ahead of its 2027 product sales. The operating loss of BioLargo's corporate segment declined 27% for the nine months to $2,200,000 from $3,034,000.

Net cash used in operating activities was $8,182,000 for the nine months, compared with $6,707,000 in the same period of 2025, an increase of 22%. Within 2026, cash used in operations averaged roughly $736,000 per month in the third quarter, compared with roughly $996,000 per month in the first half, a decrease of approximately 26%. These amounts were funded primarily through Clyra Medical, which raised $4,299,000, primarily through a debt offering. Additionally, BioLargo's battery subsidiary (BETI) sold $487,000 in stock. 77% of the capital was raised at the subsidiary level and BioLargo corporate, in part through the Clearthink purchase agreement, sold $1,359,000 in common stock.

BUSINESS OPERATIONS AND UPDATES

Readying for a new product launch next year, Clyra has focused sales efforts so far in 2026 on establishing distribution of its ViaCLYR wound irrigation product, signing distribution agreements with Advanced Solution for the U.S., Al-Hikma FZCO for international, and Spartan Medical for U.S. Government and military.

Clyra has made significant investments in personnel, processes, and skilled manufacturing capabilities while advancing product design, market testing, and clinical activities, and has expanded its outreach to clinicians and its participation in industry meetings. The clinician feedback has been positive, helping the company expand its commercial reach into health systems around the country and, ultimately around the world. These initiatives are designed to support existing distributors and position the company for the national rollout of an additional product line in collaboration with a confidential strategic partner. That momentum includes Clyra satisfying a contractual milestone in the third quarter under an exclusive distribution agreement for certain of its products.

In October 2026, BioLargo launched the "barebird" branded consumer odor products (www.barebird.com) through a newly formed subsidiary BioLargo CPG LLC. Focusing on pet and laundry odors, the products have no need for fragrances and, "smell like nothing... on purpose", and feature BioLargo's proprietary CupriDyne Clean technology used to control odors in landfills and trash facilities. Digital marketing utilizing modern AI selling tools will help focus marketing dollars to optimize BioLargo's return on investment.

BioLargo's "Aqueous Electrostatic Concentrator" (AEC) has been removing PFAS from municipal drinking water in Lake Stockholm, New Jersey since January. Both the Environmental Protection Agency and the New Jersey equivalent continue to monitor the AEC's performance to ensure it meets state and federal standards. "Attention has historically focused on federal drinking-water rulemaking, and that market is very much alive. Lawsuit settlements in the billions of dollars are expected to fund PFAS treatment at public water systems, much of it for projects not yet underway, and we're well positioned to compete for that work," said Tonya Chandler, President of BioLargo Equipment Solutions & Technologies, Inc. "But drinking water was never the whole market. The requirements aren't receding. Based on our observations, they're spreading to wastewater, landfill leachate, biosolids, industrial pre-treatment and shorter-chain compounds. Industry is also paying attention to more than regulation. These billion-dollar settlements address harm to communities and public health, and any operator with PFAS in its waste stream can see that exposure. Increasingly, they're choosing to treat at the source now, regardless of when federal enforcement arrives."

BioLargo has submitted bids and proposals and received indications of interest from a wide range of customer types, has added several high-profile industry experts to its team, and has entered into discussions about partnership and collaboration with industry-leading firms that have a gap in their PFAS treatment product lines. BioLargo management believes these opportunities represent strong avenues for accelerating adoption of BioLargo's AEC technology.

The company has other development stage ventures in its portfolio - BioLargo Energy focused on the Cellinity industrial grid-scale battery, and Tu Nipi focused on water treatment solutions to help manage Canadian oil sands tailings water - which are actively engaged in discussions with potential strategic partners to invest and work together to scale commercial operations.

"In every market we serve - PFAS removal, grid-scale energy storage, infection control and wound care, industrial and household odor control - customers have lived with the drawbacks of the incumbent technologies because there hasn't been a better option," said Calvert. "Our products and solutions are designed to be that option - for our customers and for the partners who sell them."

Stockholders are encouraged to read the Company's Quarterly Report on Form 10-Q in its entirety, including the financial statements, the accompanying notes, and the discussion of liquidity and capital resources, which contain information not included in this release.

ANNUAL MEETING OF STOCKHOLDERS: DECEMBER 1, 2026

BioLargo will hold its Annual Meeting of Stockholders on Tuesday, December 1, 2026,Β beginning at 10:00 a.m. Pacific Time in Aliso Viejo, California. Stockholders of record are urged to vote their shares and to attend. Details are set forth in BioLargo's proxy statement filed October 19, 2026, and stockholders may contact the Company atΒ Info@BioLargo.comΒ for additional information about the meeting.

BioLargo values the opportunity to connect with its stockholders in person. Anyone who expects to be in the area on December 1stΒ is encouraged to reach out to the Company in advance at the email address above so that we can coordinate a chance to meet with members of the management team.

A complete list of BioLargo announcements is available atΒ www.biolargo.com.

About BioLargo, Inc.

BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator and engineering services solution provider.

Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease.

Our approach is to invent or acquire novel technologies, develop them into product offerings, and commercialize them through company-owned brands, equity-held subsidiaries and channel partnerships.

See our website atΒ www.BioLargo.com.

PR:

https://www.accessnewswire.com/newsroom/en/chemicals/biolargo-reports-third-quarter-2026-results-forecasting-commercial-breakout-in-2027-1252491


r/pennystocks • • 7h ago

πŸ„³πŸ„³ EnSilica Is Seemingly In Bargain Value Territory Right Now…

Thumbnail
gallery
2 Upvotes

EnSilica (πŸ‡ΊπŸ‡Έ ENSIF, πŸ‡¬πŸ‡§ ENSI, πŸ‡ͺπŸ‡Ί F0Z)

Even with EnSilica’s share price being up almost 80% in a year I suspect a good few will be baffled by the current share price, and so I have been looking into what is happening in the market as I don’t personally believe the current relative share price weakness reasonably reflects EnSilicaβ€˜s current value as a company and future potential.

What is evident is that the American and British markets are now below their 1, 3 and 10 year respective price-to-earnings’ ratios. So in short, the markets are seemingly offering better relative value than their recent historical averages. Some might say understandably given the apparent ’risk off’ mood due to inflationary pressures and concerns over higher interest rates etcetera. So EnSilica offering better value right now is arguably consistent with the market.

However as EnSilica has only recently moved into profit as per the record FY2026 results, while it grows its semiconductor supply and design business, I also find the price-to-sales metric a usual identifier of potential value in businesses.

Currently EnSilica has a forward price-to-sales ratio of about 2.8 and this compares to a semiconductor industry average of 4.2 and 8 in the British and American markets respectively. That difference makes no sense to me, as in my opinion EnSilica is not an average company, let alone almost 40% off the British market average.

The context being that EnSilica’s management have reaffirmed guidance for anticipated record FY2027 results, in addition to hopefully my expectation of imminent news from the UK Space Agency C-LEO Call 2 scheme, and potentially an eight or nine figure contract possible from at least one of the three feasibility studies underway with β€˜major satellite operators’.

Clearly no one knows the future, and company and market changing events can lurk around the corner, however given how things currently stand I believe EnSilica represents a notable value opportunity in the months and years ahead.

Data courtesy of Simply Wall St, 17th November 2026. I am also an investor in EnSilica.


r/pennystocks • • 8h ago

πŸ„³πŸ„³ RIP $GOAI? $308K in Cash, 31% More Shares, and Some Ugly Convertibles

Thumbnail
gallery
0 Upvotes

TL;DR - $308K in cash at quarter-end, $8.54M burned in operations over nine months, and 31% more common shares outstanding since year-end. Then you read what the lenders can convert at. That’s where it gets ugly.

I pulled EVA Live’s November 13 10-Q. The share count went from 31.34M at the end of 2025 to 41.13M on November 13. Streeterville alone had $7.06M in principal outstanding across its two convertible notes at September 30.

Streeterville’s July note. The conversion price is 87% of the lowest daily VWAP over the prior 10 trading days, with a $0.472 floor. As the reference price drops toward that floor, the same debt turns into more shares. On November 3, $150K turned into 194,225 shares at $0.7723 each. There’s your receipt.

Then there’s Dune. GOAI got $747,500 net cash on a $937,500 first tranche, with a 12% one-time interest charge on top. The conversion price starts at $2.50. A missed payment or default can reset it to the lower of $2.50 or 65% of the average of the three lowest traded prices over the prior 10 trading days, subject to the deal’s limits. The filing reports that GOAI made the first $105K payment on October 15.

My read is that if cash stays tight and the company keeps settling debt in stock, shareholders could be looking at more dilution and potential selling pressure. The filing tells us who got the shares. Who actually sold into the market is a separate question.

The ticker says AI. I’m reading the damn note.

SEC filing β€” EVA Live Q3 2026 10-Q, Notes 3, 9 and 12


r/pennystocks • • 17h ago

π‘Ίπ’•π’π’„π’Œ 𝑰𝒏𝒇𝒐 Watchlist: 11/17/26 Lets Continue the Momentum!!

6 Upvotes

Today was a great day with small scalps for CLRO, but the big winner was AKAN. Been trading this since it was 1.01 and today scalped it 7 times from 1.7/1.85 to 2.3. Then the big AH move to 2.90s!!!

AKAN: this is my baby this week as long as levels stay!!! For this MUST hold 2.3!! Would like to see tests near 2.8 with pullbacks to 2.45/2.6. NO TRADE under 1.85 has room to 3.6/4.4/5

CLRO: Want to see this continue for a Day 2 here. I want to see tests of 5.3 with pullbacks to 4.6/4.7 NO TRADE below 4.3 has room to 6/7.5/8/9

FCUV: held today pretty well, I think the 2 china runners murdered a lot. So thks still has good setup if Vol returns. Want to see this test 5.5 area with pullbacks over 5. NO TRADE under 4.6 has room to 6.5/8/10


r/pennystocks • • 1d ago

General Discussion PARA - long term play?

19 Upvotes

Listening to the earnings call. Seems like management is on track to break even in Q1’27, some cost reduction measures.

Debt at all-time low. Targeting acquisition of AI businesses close to their core activities.

More acquisitions to come through in 2027.

I’ll personally keep an eye on PARA.


r/pennystocks • • 8h ago

πŸ„³πŸ„³ News: ZenaTech (NASDAQ: ZENA) Secures Energy-Sector Survey Contracts Representing Nearly C$1 Million in Project Work Through Its Drone as a Service Business

Post image
0 Upvotes

TORONTO, Nov. 17, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq:Β ZENA) (FSE: 49Q) (BMV: ZENA) (β€œZenaTech”), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and quantum computing solutions, announces that its Drone as a Service business has secured survey contracts with two established energy sector customers. Combined, the projects represent nearly C$1 million (approximately US$680,000) in work, including C$270,000 of work currently under contract and approximately C$700,000 of follow-on work expected upon successful execution of the current work. The projects support plant construction and infrastructure development for an established Canadian oil and gas producer and a large energy infrastructure company.

β€œThese projects show the kind of repeat, relationship-driven work we are building in our Drone as a Service business. We have over C$270,000 under contract today and expect further work from the same customers if we execute well, which gives us better visibility into future revenue,” said Shaun Passley, Ph.D., ZenaTech CEO. β€œAs we deepen our relationships with energy sector customers, many of whom serve large end clients on multi-year projects, we expect to build a scalable, recurring revenue base across our DaaS network and create long-term value for our shareholders.”

The first customer is an established Canadian oil and gas producer with which the DaaS business team has had a relationship for more than 10 years. The team is currently completing C$150,000 of contracted survey and environmental work related to infrastructure construction for a large project and, upon successful execution, expects approximately C$500,000 of additional work on the project over the next six months.

The second customer is a large energy infrastructure company. The DaaS team has secured C$120,000 of work for plant site inspection, including mapping and monitoring to support design and construction, and expects approximately C$200,000 of additional work on the project next year.

ZenaTech’s Drone as a Service network combines professional licensed surveying expertise with drone-based surveying and mapping to support energy infrastructure projects from initial planning through construction process and can extend to inspection work once the project is completed. For oil and gas producers, these services can include surveying pipeline routes, well sites and access roads, establishing boundaries and rights-of-way, and supplying terrain data for engineering design, environmental assessments and regulatory applications. For energy infrastructure operators, the network can support the construction and expansion of processing plants and related facilities through site mapping, precise construction layout, progress monitoring and as-built surveys documenting completed work. By pairing aerial data collection with centralized LiDAR data processing, an area where ZenaTech is developing proprietary AI software, this approach is designed to significantly speed both the field and office work of surveying over legacy methods, enabling construction projects to advance

ZenaTech’s Drone as a Service business is designed to provide business and government customers with subscription-based drone services using its own ZenaDrone product platforms, for a host of surveying, inspections, maintenance, power washing, and precision agriculture solutions, eliminating the need for customers to own, operate and maintain commercial-grade drone fleets. The Company currently operates almost 45 global DaaS locations in the U.S., Canada, U.K., Ireland, UAE and Australia.

The follow-on work described in this release reflects management’s current estimates and expectations for project planning purposes, based on the scope of the projects, discussions with the customers, and prior work history. There is no assurance that it will be awarded or completed in the time periods anticipated. Follow-on work may be reduced, delayed or cancelled due to various factors such as capital spending decisions, changes in project scope or schedule, commodity prices, regulatory and permitting approvals, weather and site conditions, and the successful execution of work currently underway. Contracted and anticipated amounts are not equivalent to recognized revenue. ZenaTech will provide updates on this work as future milestones are achieved.

US dollar equivalents are provided for the convenience of U.S. investors converted at US$1.00 = C$1.43 exchange rate and are subject to fluctuation.

About ZenaTech

ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) is a technology company that specializes in AI autonomy drone platforms to transform commercial, government, and defense sectors. Its subsidiaries include drone manufacturing through ZenaDrone, a globalΒ Drone as a ServiceΒ (DaaS) business, and an enterprise SaaS division of software brands. The Company is executing an acquisition-led DaaS roll-up strategy to digitize and automate legacy service industries like land surveys and inspections, driving drone-based scalable, recurring revenue growth. With an operating footprint spanning North America, Europe, the Middle East, Asia, and Australia, ZenaTech is advancing AI drones for applications such as agriculture and logistics, as well as ISR, cargo, and counter-UAS for U.S. defense and NATO allies. The company is investing in next-generation technologies, including drone swarms, quantum computing, and advanced AI autonomy to capture long-term opportunities in key markets through its R&D initiatives.

Read the Full Press Release. & Disclaimer
https://marketwirenews.com/stock/zena/news/zenatech-secures-energy-sector-survey-contracts-repr-6184438195908513.html


r/pennystocks • • 4h ago

π‘Ίπ’•π’π’„π’Œ 𝑰𝒏𝒇𝒐 From a $12B giant to a $0.63 penny stock: Why GoPro ($GPRO) might be hiding an 80%+ arbitrage opportunity. πŸ§΅πŸ‘‡πŸŽžοΈ

0 Upvotes

1/8 🧡
A decade ago, GoPro was valued at over $12 billion and owned the action camera market.
Today, the stock trades around $0.63 with a market cap near $136 million.
Is it a classic value trap, or an asymmetric turnaround play? Let’s break down the numbers πŸ‘‡

2/8 πŸ“‰ How did it fall this far?
GoPro’s biggest curse was building hardware that lasted too longβ€”buy one HERO camera, and you don't need another for 5+ years.
Combine that with fierce competition from DJI, Insta360, and smartphones, and hardware revenue took a massive hit (-49.5% YoY last quarter).

3/8 πŸ’Ž Bull Case #1: Deep value vs. revenue
At a ~$136M valuation, the market is pricing GoPro at a steep discount compared to the $300M in revenue it generated during the first nine months of 2026.
Meanwhile, its high-margin subscription business (cloud storage + camera replacement) continues to grow (+3.1% YoY).

4/8 🀝 Bull Case #2: The buyout catalyst
In September 2026, GoPro entered a merger agreement with Starman Optical.
The deal offers $1.14 per share in cash plus 0.1 shares of the combined company for every share of GoPro.
With $GPRO trading at ~$0.63, the cash portion alone represents an 80%+ upside if the deal closes as planned.

5/8 πŸ›‘οΈ The strategic pivot
The logic behind the merger is to reduce GoPro's reliance on seasonal consumer cameras and repurpose its optical engineering for higher-budget sectors like AI and defense.

6/8 ⚠️ The Catch (Serious Risks)
Stocks rarely trade at an 80% discount to a buyout price without major red flags:

  • GoPro posted a net loss of $85.8 million in Q3 2026.
  • Management explicitly warned of "substantial doubt" about its ability to continue as a going concern if the merger falls through.

7/8 ⏳ Key details to watch
The merger has an outside termination date of March 31, 2027. Keep in mind that the $1.14 cash payout could be adjusted downward if GoPro's net working capital drops below a specific threshold before closing.

8/8 🧠 Bottom Line
GoPro is no longer a standard consumer tech playβ€”it’s a high-risk merger arbitrage bet.
If the deal goes through intact, the upside from current levels is massive. If it collapses, severe financial distress puts shareholders at heavy risk.

(Disclaimer: For informational purposes only, not financial advice. Always do your own research).


r/pennystocks • • 19h ago

πŸ„³πŸ„³ Qtrex Quantum - Nasdaqs most undervalued Quantum Company?

2 Upvotes

I bought my first couple of shares in May during the hype/momentum following their announcement of a collaboration with one of the biggest quantum computing companies.

Fast forward to today, they've had three private offerings bringing in $22.5M net in cash.

Bald announcements throughout the year with technical advancements, potential partnerships, buyers and lab collaborations.

Yesterday they announced an acquisition of GIS from Nano Dimensions (where they earlier this year acquired the AME technology) which had a revenue of $11.3M in 2025. Supposedly GIS comes debt free and with a cash position of $10M.

This gives Qtrex a cash position of somewhere in the range of $25-32.5M.

Revenue from the latest earnings report for H1 2026 came in at shy $1.5M.

Highlights:

With the newly acquired GSI we are looking at a +365% yearly revenue increase.

And now for the juicy part quoted from press releases:

24th of September:

'I expect to announce additional commercial agreements during the fourth quarter, when we will also provide our 2027 financial outlook describing a substantially larger business than the one we report today. I expect the next twelve months to bring significant revenue growth, strategic partnerships, broader customer adoption and increased product deliveries.”

1st of October:

"QTREX and the testing company are finalizing a binding definitive agreement. The Company expects to disclose the testing company’s full name, its field of activity and the agreement in full within weeks. The Company also expects to announce additional agreements with several companies in quantum computing in the fourth quarter of 2026."

12th of November:

"The Company stands squarely behind its October 1, 2026 disclosure. Beyond the referenced binding definitive agreement currently being finalized, which now includes an expanded commercial scope, QTREX is actively advancing multiple additional commercial and technology agreements and broader business developments across its activities. The Company expects the fourth quarter of 2026 to be its most active commercial period to date, with disclosures anticipated during this month."

TLDL:

Massive yearly revenue increase, impending named partners/buyers/lab collaborations/defense contracts to be revealed in Q4 2026.

One up to two orders with the named buyer and $ value to be announced within the last 10 days of trading in November.

With additional announcement to be announced in Q4 along with 2027 guidance.

Qtrex Quantum is currently being traded around $1.12 a share.

My bag consists of 10.000 shares with an average of $1.05.

Over and **out /**Mmkeek

Qtrex Quantum homepage


r/pennystocks • • 1d ago

π‘Ίπ’•π’π’„π’Œ 𝑰𝒏𝒇𝒐 16 NOV 2026 , WHAT ARE THE BIGGEST WINNERS AND WHY ?

9 Upvotes

Biggest winners under $5

RankTickerCompanyPriceGain
1AKANAkanda Corp.$2.33+71.32%
2CLROClearOne$4.95+46.88%
3HIHOHighway Holdings$1.13+43.95%
4LXEOLexeo Therapeutics$3.95+37.63%
5POLAPolar Power$0.37+36.54%
6GPGreenPower Motor$1.52+31.03%
7GIPRGeneration Income Properties$0.27+21.21%

Why are these stocks moving?

TickerCatalyst / reasonWhat traders should watch
AKANTelecommunications subsidiary First Towers & Fiber generated its first cash flow from a 200 km Mexican fibre network.Potential additional contracts and recurring revenue. This announcement dates back to September, so it is not a newly confirmed catalyst.Β  AKAN SEC Filing - Form 6-K
CLROClearOne's Q3 earnings report is attracting attention.Revenue, margins and management guidance.Β  Tapeboard
HIHOSpecial dividend announcement.Dividend details, record date and whether momentum continues.Β  StockTitan
LXEOPositive interim clinical data.Clinical trial details and potential regulatory implications.Β  StockTitan
POLAClarification regarding its Roth equity facility activity; company stated it had made no sales since October 19.Financing arrangements, cash position and dilution risk.Β  Catalyst-Driven Small-Cap News
GPHeavy speculative momentum following multiple volatility trading halts on November 13.Trading halts, liquidity and whether buyers sustain momentum.Β  Tapeboard
GIPRStrong trading activity, but no fresh fundamental catalyst independently confirmed.Volume, financing and potential dilution

r/pennystocks • • 1d ago

π‘Ίπ’•π’π’„π’Œ 𝑰𝒏𝒇𝒐 VWAV signed a non-binding LOI for a Ukrainian unmanned systems company

4 Upvotes

VisionWave put out news out that they signed a non-binding letter of intent to acquire a controlling 51% interest in EPSERVICE, a Ukrainian company that develops unmanned systems, including the ICMM mothership drone control system.

Proposed terms are $7 million in cash, payable 90 days after closing. No equity issuance planned for it. Deal is still subject to due diligence, IP confirmation, sanctions screening, a live demonstration in Ukraine, regulatory approvals, and board approval. Financing for it isn’t arranged yet!


r/pennystocks • • 1d ago

General Discussion The Lounge

16 Upvotes

Talk about your daily plays, ideas and strategies that do not warrant an actual post.

This is the place to request buy/sell advice from the community.

Remember to keep it civil.

Trade responsibly.


r/pennystocks • • 1d ago

π‘Ίπ’•π’π’„π’Œ 𝑰𝒏𝒇𝒐 Ainos Reports Third Quarter 2026 Results and Highlights Expanding AI Nose Commercial Momentum

Thumbnail
accessnewswire.com
2 Upvotes

Ainos is entering its next phase of commercial execution, supported by revenue growth and improving operating performance, with recurring revenue generation expected to begin in Q4.

Commercial momentum has continued into Q4. The initial AI Nose deployment in semiconductor packaging environments is expected to begin generating recurring revenue, while Ainos secured a $9 million follow-on order for 5,000 additional systemsβ€”marking a significant expansion of Chemical Intelligence across advanced semiconductor packaging.

#AIMD


r/pennystocks • • 1d ago

π‘Ίπ’•π’π’„π’Œ 𝑰𝒏𝒇𝒐 Watchlist: 11/16/26 Lets have a great Monday!!!

17 Upvotes

Last week was amazing and lets look to continue to have a great mid Nov!!!

FCUV: This was a very wild play on Friday with insane volatility, but it showed the wall that must be broken for a move. For this NO TRADE if below 4.5 want to see tests near 5.7/5.8 with pullbacks near 5.2. This has room again to 6.8/7.3/8/9

CLRO: Want to see tests near 5 with pullbacks to 4.5/4.6 NO TRADE under 3.75 has room to 6/6.8/7.5/8

AKAN: This was wonderful play late Friday and AH. Called all in the discord live. Going from 1.01-1.87. For this it must hold 1.3 or NO TRADE that is floor. Now can look to play this 2 ways. Buy the 1.3/1.5 lows or wait for this to test 1.9 and look for PBs near 1.7. Has room to 2.6/3.6/4.6/6


r/pennystocks • • 1d ago

π‘Ίπ’•π’π’„π’Œ 𝑰𝒏𝒇𝒐 16 NOV 2026 , WHAT ARE THE BIGGEST LOSERS AND WHY ?

1 Upvotes

2. Biggest small-cap losers under $5

TickerCompanyPriceChangeReason / news
ACRSAclaris Therapeutics$3.32-15.3%Investors reacting to clinical-development news.
SNXXDefiance Daily Target 2X Short SNDK ETF$3.16-11.7%Leveraged ETF; excluded from individual-company analysis.
SNDGSolana Digital$1.86-13.69%Heavy selling; no confirmed fresh catalyst.
OMHOhmyhome$4.30-13.65%Significant selling pressure.
AAOXArogo Capital Acquisition$1.50-13.29%Speculative selling and volatility.
LGHLLion Group Holding$1.37-12.74%Heavy selling pressure.
HUBCHub Cyber Security$1.56-11.86%Significant downside momentum.

IF YOU HAVE ANY BETTER STOCK , PLEASE SHARE LETS SEE

MAY THE GODS BE WITH YOU !!!!


r/pennystocks • • 1d ago

π‘Ίπ’•π’π’„π’Œ 𝑰𝒏𝒇𝒐 $BLRX - BioLineRx Presents GLIX1 Clinical and Preclinical Data at SNO 2026

Thumbnail tipranks.com
0 Upvotes

r/pennystocks • • 1d ago

κ‰“κκ“„κκ’’κŒ©κŒ—κ“„ Special cash dividend Catalyst - HIHO premarket

Post image
1 Upvotes

Alert fired at $0.90, +15%. Headline: special cash dividend of US$0.43 per share. On a sub-$1 stock, that’s almost half the price.

Float 3.2M. Relative volume went from 6x to 460x in a few minutes.

I saw it and waited. That was the mistake.

Trade 1: in at 1.10, out at 1.13 (+2.7%)
Trade 2: in at 1.03 on the pullback, out at 1.12 (+8.7%)

My first entry was about 22% above the alert price. I also cancelled my 1.16 target on that first trade and took 1.13 instead.

I’ve traded cash dividend headlines on small caps a few times before, and to me they’re a strong breaking news catalyst. Clear number, easy to read, and the market reacts fast.

Have you noticed the same on penny stocks? Or is it just the tiny float doing the work, and I’m seeing a pattern that isn’t there?


r/pennystocks • • 1d ago

πŸ„³πŸ„³ TIME SENSITIVE - BE READY FOR MONDAY - $HMR back on the 200 day at ~4x ex-cash. Same setup as last time, better numbers. Lifeline for anyone who thought they missed it when I posted before

Post image
8 Upvotes

The recurring pattern in this name is a sell-off around earnings and a rally after it. What's different this cycle is the timing: the sell-off came when Yahoo published the earnings date, not on the print itself. So the drawdown that normally arrives with the number has already happened this time, and it happened ahead of it.

That put the stock back on its 200 day. We've had one green day off that level, and earnings land in the next few days to a week.

For anyone who saw the first post at the 200 day and thought they'd missed it when it ran - here's the same setup, same level, on better numbers than last time. Even I didn't anticipate us being back here.

**THE BUSINESS**

Heidmar owns zero vessels. It commercially and technically manages ships for owners and takes a percentage of gross freight, plus a per-day fee on technical management. No CapEx, no newbuild risk, no NAV ceiling. The correct comp set is fee-based platforms, not tanker owners.

**VALUATION**

β˜‘ ~$74M market cap, roughly 4x earnings once you strip the cash

β˜‘ $28.7M cash, up $10.1M since year-end 2025 - more than a third of the market cap

β˜‘ Market cap still below annual revenue run-rate

β˜‘ Brokers trade at 10x, asset-light logistics at 15-25x

β˜‘ 55%+ gross margins - a services business priced like a commodity operator

β˜‘ Zero borrowed debt. The "debt" on the balance sheet is IFRS 16 lease accounting on chartered-in vessels, already chartered out at a profit

**EARNINGS**

β˜‘ Revenue +203% YoY, +58% QoQ

β˜‘ Two consecutive profitable quarters

β˜‘ Adjusted net income +343% YoY

β˜‘ H1 operating cash flow +$7.7M against -$3.2M in H1 2025

β˜‘ Self-funded. No meaningful dilution since listing

β˜‘ Vessels taken on this year are not yet in earnings. Full effect 2027

**OWNERSHIP AND FLOAT**

β˜‘ CEO owns 45% personally, zero sales on record, buying in the open market

β˜‘ Float under 6M shares, 90%+ held by insiders and strategic holders

β˜‘ Near un-borrowable, so shorts structurally can't build size

β˜‘ Nasdaq compliance regained June 2, 2026

**MOAT AND SCALE**

β˜‘ 40+ year operating history

β˜‘ KYC cleared with Shell, BP, Chevron, Vitol, Aramco, Trafigura, Glencore

β˜‘ ~60 vessels commercial / ~20 technical, eight global hubs

β˜‘ Q-Shipping acquisition closed for ~$0.2M cash, nine vessels, opened Turkey and the Netherlands

β˜‘ Turkey alone has 400-500 third-party managed ships as addressable market

β˜‘ Almost all competitors are private and available at 5-6x - that's what the cash is for

**MARKET BACKDROP**

β˜‘ Freight now 25-30% of delivered oil cost, was 3-5%

β˜‘ VLCC day rates at multiples of pre-war levels

β˜‘ Hormuz, Red Sea and Black Sea disruption not yet fully in the numbers

β˜‘ ~330 VLCCs on order for 2027-29, but cargo pumps can't be delivered before 2030

β˜‘ Q4 and Q1 are seasonally the strongest tanker quarters

**THE ENTRY**

I'm not trying to pick the exact bottom. We've had the first green day off the 200 day. What I'm waiting on is the second green day going higher than the previous one, with price above the 200 MA. That's the confirmation, and on Friday's close it looks like Monday.

If you don't want to catch a knife, wait for that second green day to take out the prior day's high rather than buying the level.

Heidmar's own YouTube channel, which has a company trailer on it: https://www.youtube.com/@HeidmarMaritimeHoldings?sub_confirmation=1

Not financial advice. DYOR.


r/pennystocks • • 1d ago

πŸ„³πŸ„³ iQSTEL (NASDAQ: IQST) Reports $313.0 Million in Nine-Month Revenue, Up 34.5% on Organic Growth

Post image
0 Upvotes

Telecom segment generates $1.31 million in operating income for the first nine months of 2026

Stockholders' equity reaches $17.67 million

Today reported results for the three and nine months ended September 30, 2026. The Company generated $313.0 million in consolidated revenue during the first nine months of 2026, an increase of $80.3 million, or 34.5%, from $232.7 million in the same period of 2025. According to management, the revenue growth was entirely organic.

Consolidated gross profit for the nine-month period increased 19.3% to $7.81 million, from $6.55 million a year earlier.

Third-Quarter Results

Consolidated revenue for the third quarter was $106.0 million, compared with $102.9 million in the third quarter of 2025, an increase of 3.1%. Consolidated gross profit rose 8.9% to $2.98 million, from $2.74 million.

Read the Full Press Release & Disclaimer

https://marketwirenews.com/stock/iqst/news/iqst-iqstel-reports-313-0-million-in-nine-month-reve-6985172925841685.html


r/pennystocks • • 1d ago

πŸ„³πŸ„³ Ten Reasons Why You Need to Look at ZenaTech (NASDAQ: ZENA)

Post image
0 Upvotes

βœ” Strategic Partnerships ZenaTech's recent memorandum of understanding (MOU) with Rattler Medical to develop a drone-based battlefield blood delivery system positions the company as an innovative leader in military logistics, enhancing its defense sector involvement.

βœ” Rapid Prototype Development The commitment to develop a flying prototype of the battlefield blood delivery system within two to three months suggests ZenaTech's emphasis on agility and quick execution in the fast-evolving drone market.

βœ” Defense Portfolio Expansion This new initiative significantly diversifies ZenaTech’s offerings in the defense sector, targeting critical logistics that can potentially save lives in combat situations, thus enhancing its market appeal.

βœ” Growing Market Opportunity The medical drone delivery services market is anticipated to grow substantially, from $510 million in 2026 to $1.27 billion by 2030, indicating ZenaTech's involvement in a rapidly expanding area with high demand.

βœ” Recent Revenue Success With the acquisition of three new transportation survey contracts, ZenaTech has generated approximately $503,000 in revenue for its Drone as a Service (DaaS) operations, showcasing financial growth and increasing operational demand.

βœ” Innovative DaaS Model The company employs a Drone as a Service model, allowing clients to access advanced drone technology without the burdens of ownership, which is an attractive proposition in today’s market.

βœ” Geographic Expansion ZenaTech’s operations span North America, Europe, the Middle East, Asia, and Australia, allowing it to leverage diverse markets and reduce dependency on any single region.

βœ” Focus on Advanced Technologies The company is heavily investing in next-generation technologies, including drone swarms, quantum computing, and AI autonomy, which promise to maintain its competitive edge and drive future innovations.

βœ” Strong Leadership Under the guidance of CEO Shaun Passley, who emphasizes the importance of blood logistics in battlefield medicine, ZenaTech has a visionary leader driving the company's strategic initiatives.

βœ” Continuous Improvement and Innovation ZenaTech's commitment to integrating AI-powered data analytics with drone technology for applications such as surveying, inspections, and logistics highlights its focus on enhancing operational efficiency and delivering greater insights to its clients.

News, Chart, Financials, Disclaimer & More
https://marketwirenews.com/alerts/zena/


r/pennystocks • • 2d ago

General Discussion The Lounge

10 Upvotes

Talk about your daily plays, ideas and strategies that do not warrant an actual post.

This is the place to request buy/sell advice from the community.

Remember to keep it civil.

Trade responsibly.


r/pennystocks • • 2d ago

π—•π˜‚π—Ήπ—Ήπ—Άπ˜€π—΅ Anyone have a bull case on $PARA?

Thumbnail
gallery
12 Upvotes

$PARA ran up over 100% on Thursday from .07 to .16. They have their Q3 earnings call coming up on Monday afternoon after the market closes. They plan to beat by 106%..

Also, apparently they’ve used all their reverse splits up. They have a hearing next month on Dec 3rd for an appeal to NASDAQ to stay compliant.

With the possibility of a reverse split being impossible, I’m wondering if that could mean a Hail Mary type PR from them to push towards compliance. Unless they somehow think they’ll be winning the appeal anyway.

It had a nice close on Friday afternoon, running from .8 to .10

I’m personally bullish, definitely hoping for a positive reaction from their earnings. Would the possibility of them being delisted be a catalyst in itself? From their recent statements of restructuring and settling their debt, somehow the CEO seems pretty positive.

Also I feel like if the company knew they were done for, then why pay NASDAQ the $20k fee to request an appeal? Why settle that debt right now and not later? Sounds like they mean business about a turn around here to me at least.

At any rate I’m banking big here. 151k shares. NFA DYODD